Actively Recruiting
Effect of Kangaroo Care on Test Weighing
Led by Istanbul University - Cerrahpasa · Updated on 2025-05-02
46
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will be conducted with the Crossover Randomized Controlled Method. The infants who have attained oral feeding in the neonatal intensive care unit will be divided into two groups via randomization in the computer environment. After the randomization, kangaroo care will be applied to the infants in Group 1 during the first feeding hour when they are included in the study and they will be breastfed by their mothers without any other application during the next feeding. On the other hand, no application will be performed on the infants in Group 2 during the first feeding hour when they are included in the study and kangaroo care will be applied to them during the second feeding hour. The infants in both groups will be breastfed by their mothers during the feeding hours.
CONDITIONS
Official Title
Effect of Kangaroo Care on Test Weighing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Parents agree to participate in the study
- Infant has started oral feeding as determined by a physician in the neonatal intensive care unit
- Infant was born at 26 to 36 weeks plus 6 days gestational age
- Infant is currently 32 to 39 weeks plus 6 days postmenstrual age
- Infant weighs 1500 grams or more
- Infant has been breastfed at least once
- Infant has no health problems other than prematurity
You will not qualify if you...
- Infant has gastrointestinal, neurological, or genetic diseases such as necrotizing enterocolitis, intracranial bleeding, hydrocephalia, omphalocele, Down syndrome, gastroschisis, or other diseases
- Infant has a condition preventing oral feeding, such as cleft palate, cleft lip, facial muscle paralysis, or craniofacial abnormalities
- Infant is receiving oxygen support
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul Medipol University
Istanbul, Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
C
Canan Genç, BSN
CONTACT
D
Duygu Gözen, Assoc. Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here